DNA Patents and Human Dignity

Those objecting to human DNA patenting frequently do so on the grounds that the practice violates or threatens human dignity. For example, from 1993 to 1994, more than thirty organizations representing indigenous peoples approved formal declarations objecting to the National Institutes of Health's (NIH) bid to patent viral DNA taken from subjects in Papua New Guinea and the Solomon Islands. Although these were not patents on human DNA, the organizations argued that the patents could harm and exploit indigenous peoples and violate their cultural values. NIH eventually dropped one of its patent applications. On May 18, 1995, 180 religious leaders, led by biotechnology critic Jeremy Rifkin, held a press conference objecting to DNA patenting in Washington, D.C. In their “Joint Appeal against Human and Animal Patenting,” these leaders decried any attempt to patent nature. Some of the more outspoken members of the Joint Appeal likened DNA patenting to slavery, while others objected to treating human beings as marketable commodities. In his recent book, The Biotech Century, Rifkin rehashed the objections to DNA patenting voiced by members of the Joint Appeal.

[1]  Teresa K. Attwood,et al.  The Babel of Bioinformatics , 2000, Science.

[2]  R. Crespi An analysis of moral issues affecting patenting inventions in the life sciences: A European perspective , 2000, Science and engineering ethics.

[3]  E. Marshall Legal Fight Over Patents on Life , 1999, Science.

[4]  B. Knoppers Status, sale and patenting of human genetic material: an international survey , 1999, Nature Genetics.

[5]  D. Resnik The Human Genome Diversity Project: Ethical Problems and Solutions , 1999, Politics and the Life Sciences.

[6]  D. Nelkin,et al.  Homo economicus: commercialization of body tissue in the age of biotechnology. , 1998, The Hastings Center report.

[7]  A. Gibbons,et al.  Which of Our Genes Make Us Human? , 1998, Science.

[8]  J J Doll,et al.  The Patenting of DNA , 1998, Science.

[9]  Leonard,et al.  Disease Gene Patenting Is a Bad Innovation. , 1997, Molecular diagnosis : a journal devoted to the understanding of human disease through the clinical application of molecular biology.

[10]  M. Hanson Religious voices in biotechnology: the case of gene patenting. , 1997, The Genetic resource.

[11]  M. Hanson Religious voices in biotechnology: the case of gene patenting. , 1997, The Hastings Center report.

[12]  T Friedmann,et al.  Overcoming the obstacles to gene therapy. , 1997, Scientific American.

[13]  D. Resnik The Morality of Human Gene Patents , 1997, Kennedy Institute of Ethics journal.

[14]  Rebecca S. Eisenberg,et al.  Structure and function in gene patenting , 1997, Nature Genetics.

[15]  C. Mitchell,et al.  Patenting life: no. , 1996, First things.

[16]  L. Andrews Surrogate Motherhood: The Challenge for Feminists , 1988, Law, medicine & health care : a publication of the American Society of Law & Medicine.

[17]  J. Olsen,et al.  The European Commission , 2020, The European Union.

[18]  John T. Cunningham,et al.  New Jersey , 1896, The Journal of Comparative Medicine and Veterinary Archives.

[19]  D. Resnik DNA patents and scientific discovery and innovation: Assessing benefits and risks , 2001, Science and engineering ethics.

[20]  D. Resnik Regulating the market for human eggs. , 2001, Bioethics.

[21]  M. Hanson Biotechnology and commodification within health care. , 1999, The Journal of medicine and philosophy.

[22]  Mark Sagoff,et al.  DNA patents: making ends meet. , 1999 .

[23]  Dorothy Nelkin and M. Susan Lindee The DNA Mystique , 1995 .

[24]  Bruce Russell Pornography, Sex, and Censorship , 1991 .

[25]  R. Eisenberg Patenting the human genome. , 1990, Emory law journal.

[26]  E. Anderson Is women's labor a commodity? , 1990, Philosophy & public affairs.